Anika Therapeutics (ANIK) Nyanmɛn Kpɛn
Anika Therapeutics
Nɛnɛn kpanlan$20.40Kpɛn 25 Sep 2026 19:59 UTC
Chɛ̀ndʒ+0.54%
AI bɛ́nɛ́nɛ́: ANIK
AI bɛ sɔhɛn sɛn na ɛbɛ yɛ a ɛwɔ nna a ɛdi akyi, nnwɔtwe no awieeɛ ne bosome no awieeɛ. Nsakraeɛ no yɛ nea wɔhwɛ firi sika a ɛwɔ hɔ seesei. Eyinom yɛ nkyɛmu nhyehyɛeɛ, ɛnyɛ nkyɛmu a wɔde bɛyɛ adwuma.
Prix su les 6 mois derniers
Premium ɛn nyɛ AI sika tɔnɔw 1 da, 1 kɛsɛli kɛn 1 bɛn fɔlɔ ni sika tɔnɔw a ni ahunye bɛɛ.
Yɛ́lɛ́ Premium🔒 Nzɛnkan nyinmɛn
Kpɛnɛn nyanmiɛn su lɛlɛ su — kpɛnɛn nyanmiɛn su lɛlɛ kun'n su, su'n su kpɛnɛn su lɛlɛ kun'n su — yɛ Premium su.
Yɛ́lɛ́ PremiumNyanmiɛn nɛnɛn
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The company’s hyaluronic acid-based products promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika’s product portfolio includes ORTHOVISC and HYVISC, which are used to treat osteoarthritis.
